BioCrude Technologies USA, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
BioCrude Technologies USA, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2017 to Q2 2024.
  • BioCrude Technologies USA, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$64.5K, a 31.9% increase year-over-year.
  • BioCrude Technologies USA, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$275K, a 2.24% decline year-over-year.
  • BioCrude Technologies USA, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$244K, a 34.5% decline from 2022.
  • BioCrude Technologies USA, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$182K, a 57.9% increase from 2021.
  • BioCrude Technologies USA, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$431K, a 49.6% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$275K -$64.5K +$30.2K +31.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 -$305K -$124K -$61.1K -98% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-09
Q4 2023 -$244K -$37.8K -$15.1K -66.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 -$229K -$49.3K +$39.9K +44.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$269K -$94.7K -$79.2K -511% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$190K -$62.4K -$8.35K -15.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-09
Q4 2022 -$182K -$22.7K +$44.9K +66.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 -$226K -$89.3K -$42.4K -90.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$184K -$15.5K +$138K +89.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-13
Q1 2022 -$322K -$54K +$110K +67% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-13
Q4 2021 -$431K -$67.6K Oct 1, 2021 Dec 31, 2021 10-Q 2022-05-10
Q3 2021 -$46.9K Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-08
Q2 2021 -$153K Apr 1, 2021 Jun 30, 2021 10-Q 2021-11-08
Q1 2021 -$164K -$142K -655% Jan 1, 2021 Mar 31, 2021 10-Q 2021-11-08
Q1 2020 -$21.7K +$36.9K +63% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-12
Q1 2019 -$58.5K +$688K +92.2% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-14
Q3 2018 -$1.04M -$59.3K +$172K +74.4% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-08
Q2 2018 -$1.22M -$29.2K +$402 +1.36% Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-24
Q1 2018 -$1.22M -$747K -$694K -1318% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$523K -$209K Oct 1, 2017 Dec 31, 2017 10-K 2019-04-17
Q3 2017 -$232K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$29.6K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-24
Q1 2017 -$52.7K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.